My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 160

    1.

    Loss-of-function genetic diseases and the concept of pharmaceutical targets.

    Ségalat L.

    Orphanet J Rare Dis. 2007 Jul 2;2:30.PMID: 17605800 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Loss-of-function genetic diseases and the concept of pharmaceutical targets.

    Ségalat L.

    Orphanet J Rare Dis. 2007;2:30. Review.PMID: 17674486 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Targetability of human disease genes.

    Sakharkar MK, Sakharkar KR.

    Curr Drug Discov Technol. 2007 Jun;4(1):48-58. Review.PMID: 17630928 [PubMed - indexed for MEDLINE]Related articles

    4.

    Genetics in drug discovery and development: challenge and promise of individualizing treatment in common complex diseases.

    Lindpaintner K.

    Br Med Bull. 1999;55(2):471-91. Review. No abstract available. PMID: 10723870 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Pharmacogenomics and the drug discovery pipeline: when should it be implemented?

    Penny MA, McHale D.

    Am J Pharmacogenomics. 2005;5(1):53-62. Review.PMID: 15727489 [PubMed - indexed for MEDLINE]Related articles

    6.

    Human monogenic disorders - a source of novel drug targets.

    Brinkman RR, Dubé MP, Rouleau GA, Orr AC, Samuels ME.

    Nat Rev Genet. 2006 Apr;7(4):249-60. Review.PMID: 16534513 [PubMed - indexed for MEDLINE]Related articles

    7.

    The identification and validation of common disease genes: relevance to the drug development process.

    Holmberg M, Lejon K.

    Curr Opin Mol Ther. 2001 Dec;3(6):533-7. Review.PMID: 11804267 [PubMed - indexed for MEDLINE]Related articles

    8.

    The increasing importance of genetic variation in drug discovery and development.

    Labaudinière R.

    Curr Opin Mol Ther. 2002 Dec;4(6):559-64. Review.PMID: 12596357 [PubMed - indexed for MEDLINE]Related articles

    9.

    Pharmacogenetics.

    Vesell ES.

    Biochem Pharmacol. 1975 Feb 15;24(4):445-50. No abstract available. PMID: 1167457 [PubMed - indexed for MEDLINE]Related articles

    10.

    Overview of pharmacogenetics.

    Katz DA, Bhathena A.

    Curr Protoc Hum Genet. 2009 Jan;Chapter 9:Unit 9.19. Review.PMID: 19170034 [PubMed - indexed for MEDLINE]Related articles

    11.

    Richard Weinshilboum: Pharmacogenetics: The future is here!

    Weinshilboum R.

    Mol Interv. 2003 May;3(3):118-22.PMID: 14993417 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Developmental and pediatric pharmacogenomics.

    Leeder JS.

    Pharmacogenomics. 2003 May;4(3):331-41. Review.PMID: 12718723 [PubMed - indexed for MEDLINE]Related articles

    13.

    Novel methods for detecting epistasis in pharmacogenomics studies.

    Motsinger AA, Ritchie MD, Reif DM.

    Pharmacogenomics. 2007 Sep;8(9):1229-41. Review.PMID: 17924838 [PubMed - indexed for MEDLINE]Related articles

    14.

    Aminoglycoside-induced translational read-through in disease: overcoming nonsense mutations by pharmacogenetic therapy.

    Zingman LV, Park S, Olson TM, Alekseev AE, Terzic A.

    Clin Pharmacol Ther. 2007 Jan;81(1):99-103. Review.PMID: 17186006 [PubMed - indexed for MEDLINE]Related articles

    15.

    Systems approaches for pharmacogenetics and pharmacogenomics.

    Bader JS.

    Pharmacogenomics. 2008 Mar;9(3):257-62. No abstract available. PMID: 18303961 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Connecting chemosensitivity, gene expression and disease.

    Covell DG.

    Trends Pharmacol Sci. 2008 Jan;29(1):1-5. Epub 2007 Dec 4.PMID: 18055024 [PubMed - indexed for MEDLINE]Related articles

    17.

    Protein misfolding disorders and rational design of antimisfolding agents.

    Estrada LD, Yowtak J, Soto C.

    Methods Mol Biol. 2006;340:277-93. Review.PMID: 16957342 [PubMed - indexed for MEDLINE]Related articles

    18.

    Human genetic variation and personalized medicine.

    Agrawal S, Khan F.

    Indian J Physiol Pharmacol. 2007 Jan-Mar;51(1):7-28. Review.PMID: 17877289 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Pharmacogenetics: forerunner for individualized medicine]

    Lindpaintner K.

    Ther Umsch. 2003 Aug;60(8):487-92. German. No abstract available. PMID: 14502858 [PubMed - indexed for MEDLINE]Related articles

    20.

    Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations.

    Nudelman I, Rebibo-Sabbah A, Shallom-Shezifi D, Hainrichson M, Stahl I, Ben-Yosef T, Baasov T.

    Bioorg Med Chem Lett. 2006 Dec 15;16(24):6310-5. Epub 2006 Sep 25.PMID: 16997553 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk